Cerebras Systems Inc <CBRS.O>: Mizuho cuts target price to $300 from $310
CBRS•Related News
Cabaletta Bio Q2 FY26 net loss narrows 11.69% to $51.02 million; R&D expenses rise 18.06% to $44.43 million
CABA•
Journey Medical climbs after quarterly revenue beat
DERM•
Monro declares quarterly cash dividend of $0.28 a share
MNRO•
Cerebras Systems <CBRS.O>: Morgan Stanley raises target price to $279.00 from $273.00
CBRS•
MiNK Therapeutics Q2 loss narrows on expense discipline
INKT•